Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

2
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Patterns of presentation, treatment, and survival among older adults with metastatic breast cancer: Results from a large prospective registry.

Journal of geriatric oncology·2025
Same author

A Case study of polypharmacy-induced serotonin syndrome in a cancer patient.

Journal of the American Association of Nurse Practitioners·2024
Same author

Essential Review of Oncological Emergencies.

Critical care nursing quarterly·2024
Same author

To choose or not to choose a nurse practitioner fellowship: An opinion piece on why to choose.

Journal of the American Association of Nurse Practitioners·2024
Same author

A case study of myopericarditis due to immune checkpoint inhibitor therapy: Proposed surveillance and management.

Journal of the American Association of Nurse Practitioners·2023
Same author

Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer.

Journal of the advanced practitioner in oncology·2021

相关实验视频

Updated: Jun 12, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

癌性心脏病 癌性心脏病

Nicole Kuhnly1, Jessica Shank Coviello2, Catherine A Kobza3

  • 1From Memorial Sloan Kettering Cancer Center, New York, New York.

Journal of the advanced practitioner in oncology
|September 27, 2024
PubMed
概括

癌症性心脏病 (CHD),神经内分泌瘤和癌症综合征的罕见并发症,需要多学科的护理. 早期诊断和管理对于改善这种晚期心力衰竭患者的治疗结果至关重要.

更多相关视频

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.2K

相关实验视频

Last Updated: Jun 12, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.6K
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.2K

科学领域:

  • 心脏病学 心脏病学
  • 在瘤学瘤学.
  • 内分泌学 在内分泌学.

背景情况:

  • 癌症性心脏病 (CHD) 是一种罕见的心脏并发症,与晚期神经内分泌瘤 (NETs) 和癌症性综合征有关.
  • NETs,特别是小肠瘤,最常与心脏病有关.
  • 癌症性综合征涉及血清素的释放,导致脸红,腹,支气管缩和心力衰竭症状.

研究的目的:

  • 为了突出管理癌性心脏病的挑战.
  • 强调需要一种协作,多学科的方法来管理CHD.
  • 强调量化疾病负担和延迟膜疾病进展的重要性.

主要方法:

  • 审查有关癌症性心脏病和癌症性综合征的现有文献.
  • 分析CHD的典型表现和进展.
  • 讨论涉及多个医学专业的协作护理模式.

主要成果:

  • 心血管疾病的预后很差,对于未经治疗的高级心力衰竭患者,往往不到一年.
  • 晚期呈现和快速进展使心血管疾病的管理复杂化.
  • 多学科合作对于有效的患者管理至关重要.

结论:

  • 最佳的CHD管理需要协调的团队努力.
  • 战略重点是量化疾病负担,减缓膜疾病和量身定制治疗.
  • 改善生活质量和降低死亡率是心血管疾病护理的关键目标.